Main > ONCOLOGY (**) > Lung>NSCLC>MET>ALK(+) or ROS1(+) * > Treatment > Co: USA. P. Crizotinib Capsules



Co: USA. P. Crizotinib Capsules's subsections
(*) EU ROS1(+) OK: 2016. 08.31
(*) USA ALK(+) OK: 2011. 08.26
(*) USA ROS1(+) OK: 2016. 03
ALK: Anaplastic Lymphoma Kinase
Companion Diagnostics ALK(+)>
Companion Diagnostics ROS1(+)>
Company
Patent>Assignee; Claims; No.; Etc
Patent>UpDate: 2011. 08.30
Personalized Medicine
TradeMark
TradeMark Web-Site

Co: USA. P. Crizotinib Capsules's products
This section has no products